Fireside Chat: Autologous vs Allogeneic: Manufacturing models for scale and speed

Choosing the right manufacturing model is critical to delivering cell therapies efficiently and at scale. This session explores autologous and allogeneic approaches, highlighting strategies to optimize logistics, automation, and standardized production while balancing cost and patient timelines. 

Key takeaways: 

• Examine vein-to-vein logistics and automation requirements for autologous therapies 

• Explore scalable cell banks and standardized processes for allogeneic models 

• Compare scalability, cost of goods, and time-to-patient across manufacturing approaches 

• Discuss process design considerations for closed systems and high-throughput production 

• Evaluate strategic decisions to balance speed, quality, and operational efficiency